Skip to main content

Neovaginal Granulation-Tissue Debridement

Neovaginal granulation tissue is the most common postoperative complication of penile inversion vaginoplasty, with reported incidence 2–26% depending on series and definition.[1][2][3] It is a minor complication (Clavien–Dindo I–II) but is clinically meaningful because it independently predicts revision surgery, drives bleeding / dilation-pain cycles, and can progress to introital stenosis. Standard first-line management is office serial silver-nitrate cauterisation; the Gharavi 2026 matched cohort showed that adding betamethasone suppositories significantly improves resolution (p = 0.035) and reduces the number of treatments required.[1] Refractory cases escalate to EUA cauterisation, intralesional steroids, pulsed-dye laser, or surgical excision.

This is the dedicated management-pathway page. For the broader postoperative complication framework, see Neovaginal Stenosis Management (granulation tissue is the central precursor to stenosis). For the host operations, see Penile Inversion Vaginoplasty, Peritoneal Pull-Through Vaginoplasty, and Intestinal Vaginoplasty.

Definition and Pathophysiology​

Hypergranulation tissue (HGT) — also termed excess granulation tissue, proud flesh, or hypertrophic granulation — is abnormal granulation tissue raised above the level of surrounding intact skin / epithelium that impedes re-epithelialisation.[5] In the neovaginal context, it represents a dysregulated proliferative phase of wound healing within the canal, at suture lines, or at the introitus.

Normal granulation begins ~4 d after injury: macrophages, fibroblasts, and new capillaries invade the wound space; macrophages provide growth factors (PDGF, TGF-β1) that drive fibroplasia and angiogenesis; fibroblasts produce ECM scaffold — yielding the characteristic red, granular, vascular tissue.[6] Hypergranulation occurs when this process becomes dysregulated with excessive PDGF and TGF-β activity → overproduction that protrudes above the wound surface and prevents epithelial migration across the wound.[7][5]

Neovaginal-context drivers:[8][9][10]

  • Chronic mechanical irritation from repeated dilation.
  • Moisture and occlusion — warm, moist, semi-occluded canal.
  • Suture material reaction at skin-graft / native-tissue junctions.
  • Wound colonisation / infection — wound infection associated with all tissue-healing complications (Dreher meta-analysis).[10]
  • Skin-graft–recipient-bed interface — particularly at areas of incomplete graft take.
  • Wound separation / dehiscence healing by secondary intention.

Incidence​

SeriesnGranulation rateNotes
Massie 2018[2]11726%Most common complication; broad definition
Gaither 2018[11]330—Median time to complication 4.4 mo
Blickensderfer 2023 (vulvoplasty)[3]219.5%Most common complication after UTI for vulvoplasty
Raigosa 2020[4]1672.4%Persistent, requiring in-office treatment
Patel / Morrison 2021[13]18283% prolonged > 6 wk in patients later requiring labial fat grafting vs 32% controls (p = 0.01)—
Boas 2019[14]117—Significantly associated with revision (p = 0.006)

The wide 2–26% range reflects definitional heterogeneity — some count any visible granulation, others count only persistent disease requiring treatment.[2][3]

Clinical Presentation and Diagnosis​

Symptoms[12][8][15][16]​

  • Vaginal bleeding — most common presentation; spotting or blood-tinged discharge after dilation / intercourse. ACOG Committee Opinion 823 notes patients may present with "bleeding or discharge consistent with granulation tissue".[16]
  • Blood-tinged discharge.
  • Pain / discomfort with dilation — friable tissue bleeds on contact.
  • Visible red, raised, friable tissue on speculum exam.
  • Difficulty with dilation — physical obstruction, particularly if circumferential or introital.
  • Malodor — if secondarily infected.

Locations[8][9][17]​

  • Skin-graft junctions — penile-flap / scrotal-graft or graft / peritoneal-flap interfaces.
  • Introitus — mucocutaneous junction (particularly common after intestinal vaginoplasty).
  • Neovaginal apex — graft-to-peritoneum or blind-end junctions.
  • Suture lines.
  • Areas of partial graft loss healing by secondary intention.

Diagnosis​

Clinical — direct visualisation during speculum exam (Pederson speculum or anoscope).[12][16] The Gharavi 2026 study classified hypergranulation as mild, moderate, or severe — no standardised grading system exists.[1]

Differential:

  • Intravaginal hair growth (incomplete preoperative electrolysis)
  • Wound dehiscence (partial graft / flap separation)
  • Neovaginal stenosis (may coexist)
  • Infection / abscess
  • Neoplasia — extremely rare; biopsy if atypical or refractory
  • Suture granuloma — foreign-body reaction; may require suture removal

Clinical Significance — Not Just Cosmetic​

Granulation tissue is a marker of impaired wound healing with downstream consequences:

  • Predictor of revision surgery — Boas 2019: granulation tissue significantly predicted revision labiaplasty / clitoroplasty (p = 0.006) and intravaginal scarring (p < .05).[14]
  • Predictor of labial fat grafting — Patel / Morrison 2021: prolonged granulation > 6 wk in 83% of fat-grafting patients vs 32% controls (p = 0.01).[13]
  • Progression to introital stenosis — recurrent granulation can drive a cycle of granulation → cautery → scarring → re-granulation; one Gupta case report described complete introital obliteration despite 2 surgical revisions, ultimately requiring UBM biological-graft reconstruction.[17]
  • Dilation-compliance disruption — granulation causes pain and bleeding during dilation → reduced dilation → stenosis → more granulation (the vicious cycle).[12][8]

Stepwise Management Algorithm​

Step 1 — Silver-nitrate cauterisation (first-line)​

ACOG-endorsed primary modality.[16][1][5]

  • Speculum (Pederson / anoscope) access.[1]
  • Silver-nitrate stick (75% AgNO₃ / 25% KNO₃) applied directly → chemical coagulation → gray-white eschar.
  • Protect surrounding normal tissue (petroleum jelly on perimeter).
  • Office setting; topical lidocaine for comfort.
  • Multiple treatments required — Gharavi 2026: median 3.5 treatments for moderate, 5 treatments for severe HGT.[1]

Outcomes alone:[1]

  • Moderate HGT resolution 60%.
  • Severe HGT resolution 25%.
  • Modest rates for moderate-to-severe disease justify adjunctive therapy.

Step 2 — Silver nitrate + betamethasone suppositories (enhanced first-line)​

Gharavi 2026 matched cohort (n = 32):[1]

ParameterSilver nitrate alone (n = 16)+ Betamethasone (n = 16)Significance
Moderate HGT resolution60%86%Trend
Severe HGT resolution25%50%Trend
Median treatments for moderate3.52Fewer
Median treatments for severe54Fewer
Overall resolution (excluding EUA cases)LowerSignificantly higherp = 0.035
Follow-up8.5 ± 5.5 mo7.8 ± 4.7 moNS

Betamethasone suppositories used between office silver-nitrate visits; deliver topical corticosteroid that suppresses the inflammatory cascade driving HGT, complementing the chemical cautery. Reduces both office-visit burden and total treatment count.[1][5]

Step 3 — Topical steroids (alternative or adjunct)​

Evidence from general wound-healing literature:[5][18][19][20]

  • Linneman 2022 — 1% hydrocortisone cream produced significantly greater wound-size reduction than silver-nitrate cautery (median 14 mm vs 5 mm decrease in length/width, p < .05).[18]
  • Brødsgaard 2015 — clobetasol propionate 0.05% cream as effective as silver nitrate for umbilical granuloma (identical healing / resolution; advantage of home application).[19]
  • Shoham 2024 burn-association survey — 78.9% of European respondents routinely use topical steroids for hypergranulation (vs 33.3% North America); European respondents significantly more likely to consider them safe (100% vs 74.4%, p < .001).[20]

Options for the neovaginal context:

  • Betamethasone suppositories (Gharavi protocol)
  • Clobetasol 0.05% cream — applied directly or on a dilator
  • Triamcinolone acetonide cream — intermediate potency
  • Hydrocortisone 1% — mild cases

Step 4 — Intralesional corticosteroid injection​

For refractory HGT:[5]

  • Triamcinolone acetonide 10–40 mg/mL into the base of granulation tissue.
  • Dermatologic literature: successful treatment in 55 cases.[5]
  • Mechanism: direct suppression of fibroblast proliferation, collagen synthesis, angiogenesis.
  • Office with local anaesthesia; risk of local tissue atrophy with repeated injections.

Step 5 — Cauterisation under anaesthesia (EUA)​

For moderate-to-severe HGT refractory to office treatment:[1][8]

  • OR with sedation or GA.
  • Complete visualisation with speculum / vaginoscope.
  • Electrocautery (monopolar or bipolar) ablation — more thorough and controlled than silver nitrate.
  • Sharp debridement with scissors / curette + electrocautery to base.
  • Concurrent assessment for other pathology (suture granuloma, retained suture, hair growth, stenosis).
  • The Gharavi study excluded EUA-requiring patients from the primary analysis.[1]

Step 6 — Surgical excision​

For recurrent, extensive, or refractory HGT failing conservative measures:[8][5][17]

  • Formal excision with primary closure or tissue rearrangement.
  • May combine with other revisions (labiaplasty, introitoplasty, stenosis management).
  • For introital HGT causing stenosis — UBM biological-graft reconstruction described as a salvage technique after 2 failed surgical revisions (Gupta 2019 case report).[17]

Step 7 — Pulsed-dye laser (emerging / adjunctive)​

For HGT refractory to silver nitrate + steroids:[5][21]

  • Dermatologic literature: 13 cases of HGT treated with PDL.[5]
  • Wang 2007 retrospective n = 9 postsurgical HGT patients — dramatic improvement after one treatment, most with complete or near-complete re-epithelialisation after 1–2 treatments. No local anaesthesia required; no postlaser complications.[21]
  • Mechanism: selective photothermolysis of the vascular component (hemoglobin absorption).
  • Settings: 595 nm, 7–10 mm spot, 4.0–8.0 J/cm², 0.45–1.5 ms pulse.[21]
  • Not yet studied in the neovaginal context specifically; mechanism and postsurgical-wound efficacy data are extrapolable.
  • Accessibility and cost limit use.

Comparison of Treatment Modalities​

ModalitySettingAnaesthesiaEfficacyBest indication
Silver nitrate aloneOfficeTopical25–60% (moderate–severe)First-line; mild–moderate[1]
Silver nitrate + betamethasoneOffice + homeTopical50–86%First-line enhanced — fewer treatments, better resolution[1]
Topical steroids aloneHomeNoneComparable to AgNO₃Mild cases; home-based[18][19][20]
Intralesional steroidsOfficeLocalEffective (55 cases in literature)Refractory localised disease[5]
EUA electrocauteryORSedation / GAHigh (thorough ablation)Refractory to office; complete visualisation needed[1]
Surgical excisionORGAHighRecurrent / extensive; revision setting[8][17]
Pulsed-dye laserOfficeNone9/9 improved (postsurgical)Refractory; emerging[21]
UBM biological graftORGACase reportSalvage for introital obliteration after failed revisions[17]

Special Considerations by Surgical Technique​

  • PIV — granulation tissue is most commonly reported here, at skin-graft junctions and suture lines; Massie 26% and Gaither identified granulation among the leading complications.[2][11]
  • Peritoneal-flap vaginoplasty — can occur at the peritoneal-flap / perineal-skin junction; the squamous-metaplasia transition zone may produce granulation during remodelling.[8]
  • Sigmoid / intestinal vaginoplasty — granulation at the colovestibular anastomosis (sigmoid mucosa / perineal skin) is the recognised complication; the Gupta case of complete introital obliteration originated here.[17]
  • Vulvoplasty (zero-depth) — granulation was the most common complication (9.5%) in the Blickensderfer series.[3]

Prevention​

Strategies to reduce HGT formation at primary surgery:[10][12][8]

  • Meticulous hemostasis — hematoma promotes granulation.
  • Tension-free closure — reduces dehiscence / secondary-intention healing.
  • Appropriate suture selection — rapidly absorbable sutures may reduce foreign-body reaction.
  • Preoperative electrolysis — prevents intravaginal hair → reduces chronic inflammation / granulation nidus.[12][16]
  • Wound-infection prevention — Dreher meta-analysis association with all tissue-healing complications.[10]
  • Gentle early dilation technique — avoid excessive trauma to healing surfaces.
  • Adequate graft fixation — complete graft take reduces secondary-intention healing.

Surveillance and Patient Counselling​

AAFP and ACOG recommendations:[12][16]

  • Pelvic exam yearly or every other year to monitor for granulation, stenosis, hair regrowth.
  • Speculum exam with Pederson speculum or anoscope to visualise the entire canal.[12]
  • Counsel patients that granulation is a common, treatable, minor complication — report bleeding / discharge / dilation-pain promptly.[12][16]
  • Regular douching with soapy water or dilute vinegar / betadine to maintain hygiene and reduce chronic inflammation.[12]

Practical Algorithm​

  1. Identify and grade (mild / moderate / severe) on speculum exam.[1]
  2. Rule out concurrent pathology — suture granuloma (remove retained suture), infection (treat), hair (electrolysis), stenosis (address separately).
  3. Mild → office silver nitrate q 2–4 wk ± betamethasone suppositories between visits.[1][16]
  4. Moderate → silver nitrate + betamethasone (median 2 treatments to resolution); if no improvement after 3–4 → intralesional triamcinolone or escalate to EUA.[1]
  5. Severe → silver nitrate + betamethasone (median 4 treatments); if refractory → EUA electrocautery ± sharp debridement.[1]
  6. Refractory / recurrent → pulsed-dye laser, surgical excision, or biological-graft reconstruction if concurrent introital stenosis.[5][17][21]
  7. Throughout — continue dilation as tolerated; optimise wound care (douching, hygiene); address modifiable factors (smoking, infection).

Evidence Limitations​

  • No RCTs for any treatment modality of neovaginal granulation tissue.[1]
  • Gharavi 2026 (n = 32) is the only comparative study specifically addressing HGT after PIV — all other evidence is extrapolated from general wound-healing, burn, and dermatologic literature.[1]
  • No standardised grading system for neovaginal HGT severity.[1]
  • No standardised treatment protocol — practice varies by institution and surgeon.
  • Pulsed-dye laser not yet studied specifically in the neovaginal context.[21]
  • The granulation–stenosis relationship is recognised but not well quantified — whether aggressive early HGT treatment prevents subsequent stenosis remains undefined.[14][13]
  • Long-term outcomes of HGT treatment poorly characterised.
  • Patient-reported outcomes (impact on dilation compliance, sexual function, QoL) not well-studied.

References​

1. Gharavi A, Sanchez Figueroa N, Lin A, Fahradyan V, Martinez-Jorge J. The addition of betamethasone suppositories to silver nitrate treatment for hypergranulation tissue following penile inversion vaginoplasty: a matched cohort study. Ann Plast Surg. 2026;96(1):79–82. doi:10.1097/SAP.0000000000004542

2. Massie JP, Morrison SD, Van Maasdam J, Satterwhite T. Predictors of patient satisfaction and postoperative complications in penile inversion vaginoplasty. Plast Reconstr Surg. 2018;141(6):911e–921e. doi:10.1097/PRS.0000000000004427

3. Blickensderfer K, McCormick B, Myers J, et al. Gender-affirming vaginoplasty and vulvoplasty: an initial experience. Urology. 2023;176:232–236. doi:10.1016/j.urology.2023.03.002

4. Raigosa M, Avvedimento S, Descarrega J, et al. Refinement procedures for clitorolabiaplasty in male-to-female gender-affirmation surgery: more than an aesthetic procedure. J Sex Med. 2020;17(12):2508–2517. doi:10.1016/j.jsxm.2020.08.006

5. Hirotsu K, Kannan S, Brian Jiang SI. Treatment of hypertrophic granulation tissue: a literature review. Dermatol Surg. 2019;45(12):1507–1516. doi:10.1097/DSS.0000000000002059

6. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341(10):738–746. doi:10.1056/NEJM199909023411006

7. Irma J, Kartasasmita AS, Kartiwa A, et al. From growth factors to structure: PDGF and TGF-β in granulation tissue formation. A literature review. J Cell Mol Med. 2025;29(11):e70374. doi:10.1111/jcmm.70374

8. Schardein JN, Zhao LC, Nikolavsky D. Management of vaginoplasty and phalloplasty complications. Urol Clin North Am. 2019;46(4):605–618. doi:10.1016/j.ucl.2019.07.012

9. Ferrando CA. Vaginoplasty complications. Clin Plast Surg. 2018;45(3):361–368. doi:10.1016/j.cps.2018.03.007

10. Dreher PC, Edwards D, Hager S, et al. Complications of the neovagina in male-to-female transgender surgery: a systematic review and meta-analysis with discussion of management. Clin Anat. 2018;31(2):191–199. doi:10.1002/ca.23001

11. Gaither TW, Awad MA, Osterberg EC, et al. Postoperative complications following primary penile inversion vaginoplasty among 330 male-to-female transgender patients. J Urol. 2018;199(3):760–765. doi:10.1016/j.juro.2017.10.013

12. Jackson Q, Yedlinsky NT, Gray M. Lifelong care of patients after gender-affirming surgery. Am Fam Physician. 2024;109(6):560–565.

13. Patel V, Morrison SD, Gujural D, Satterwhite T. Labial fat grafting after penile inversion vaginoplasty. Aesthet Surg J. 2021;41(3):NP55–NP64. doi:10.1093/asj/sjaa431

14. Boas SR, Ascha M, Morrison SD, et al. Outcomes and predictors of revision labiaplasty and clitoroplasty after gender-affirming genital surgery. Plast Reconstr Surg. 2019;144(6):1451–1461. doi:10.1097/PRS.0000000000006282

15. Krakowsky Y, Shah G, Nguyen AV, et al. Gender-affirming care in urology: emergency care of the gender-affirming surgical patient — what the primary urologist needs to know. BJU Int. 2024;133(2):124–131. doi:10.1111/bju.16249

16. Committee on Gynecologic Practice and Committee on Health Care for Underserved Women. Health care for transgender and gender diverse individuals: ACOG Committee Opinion, Number 823. Obstet Gynecol. 2021;137(3):e75–e88. doi:10.1097/AOG.0000000000004294

17. Gupta A, Francis S, Stewart R, Hobson D, Meriwether KV. Repair of colonic neovaginal stenosis using a biological graft in a male-to-female transgender patient. Int Urogynecol J. 2019;30(4):661–663. doi:10.1007/s00192-018-3800-6

18. Linneman PK, Litt J. Hypertrophic granulation wounds treated with silver nitrate sticks or with topical steroid: rate of wound closure. J Burn Care Res. 2022;43(2):403–407. doi:10.1093/jbcr/irab196

19. Brødsgaard A, Nielsen T, Mølgaard U, Pryds O, Pedersen P. Treating umbilical granuloma with topical clobetasol propionate cream at home is as effective as treating it with topical silver nitrate in the clinic. Acta Paediatr. 2015;104(2):174–177. doi:10.1111/apa.12824

20. Shoham Y, Comish P, Tsur R, et al. Topical steroid use for suppression of hypergranulation in burns: trends across the Atlantic. J Burn Care Res. 2024:irae191. doi:10.1093/jbcr/irae191

21. Wang SQ, Goldberg LH. Pulsed dye laser for the treatment of hypergranulation tissue with chronic ulcer in postsurgical defects. J Drugs Dermatol. 2007;6(12):1191–1194.